Commentary: A UT Health San Antonio doctor is studying a drug that could help treat respiratory complications after COVID-19 infection.
Author Archives: Dr. Thomas Patterson
Dr. Thomas Patterson is a clinical trialist at The University of Texas Health Science Center at San Antonio. He receives fair market compensation from PureTech, the Sponsor of the clinical study referenced in this article, for his role as the study’s principal investigator.
